申请人:GILEAD SCIENCES INC
公开号:WO2021081207A1
公开(公告)日:2021-04-29
The present disclosure provides GLP-1R agonists, and compositions, methods, and kits thereof. Such compounds are generally useful for treating a GLP-1R mediated disease or condition in a human.
本公开提供GLP-1R激动剂,以及其组合物、方法和试剂盒。这些化合物通常用于治疗人体中GLP-1R介导的疾病或症状。